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Abstract
Extramedullary hematopoiesis (EMH) is the formation and development of blood cells outside
the bone marrow, and in dogs it frequently occurs in the spleen. Although splenic EMH is a rel-
atively common condition, data regarding its appearance in veterinary medicine are lacking. Our
aim was to describe different multidetector computed tomographic (MDCT) features of splenic
EMH in dogs. In this descriptive retrospective study, dogs with cytological diagnosis of splenic
EMH and three-phase MDCT study of the abdomen were included. Multi-detector CT findings
recordedwere splenomegaly, appearance of the parenchyma, andmean attenuation of the spleen
and lesions.Outof89dogs included, 55 (62%)presentedmultifocal nodular aspect, 14 (16%)mass,
12 (13%) diffuse heterogeneous parenchyma, and eight (9%) normal spleen. Most lesions were
hyperattenuating to the parenchyma in the arterial (57/89, 64%) and portal (59/89, 66%) phases;
whereas in the interstitial phase only 40 of 89 (45%) were hyperattenuating. The mean attenua-
tions of the lesions were higher compared to the values of the adjacent spleen, and the difference
of the mean attenuation between the hyperattenuating lesions and the parenchyma was signifi-
cantly higher in arterial and portal phases than in interstitial phase (P< .0001). Themost frequent
MDCT aspect of splenic extramedullary hematopoiesis consists of multiple nodules hyperattenu-
ating to the normal spleen, best visualized in the arterial and portal phases.
K EYWORD S
canine, computed tomography, extramedullary hemopoiesis, spleen
1 INTRODUCTION
Many diseases of the spleen frequently occur in dogs, and the dif-
ferentiation between clinically relevant abnormalities and benign
findings with imaging modalities is challenging. One of the most
common conditions is splenic extramedullary hematopoiesis (EMH),
but published data regarding its appearance in veterinarymedicine are
currently lacking. Splenic masses and nodules are frequently observed
on imaging in canine patients, and the diagnosis ranges from benign
Abbreviations: EMH, extramedullary hematopoiesis; MDCT, multi-detector CT; ROI, region
of interest.
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lesions discovered incidentally (eg, nodular hyperplasia) to malignant
neoplasia, such as hemangiosarcoma.1-4
Some studies in veterinary literature described the CT character-
istics of splenic masses in dogs.5-7 Malignant masses were described
to have lower Hounsfield Unit (HU) values, with 55 HU in post con-
trast images as a threshold value to distinguish between malignant
(<55 HU) and non-malignant (>55 HU) masses, as benign nodules
(nodular hyperplasia) showed the highest enhancement.5 In a study
regarding two-phasesCTcharacteristics of hepatic and splenicmasses,
no CT features were found to be significantly associated with malig-
nant or non-malignant splenic lesions, as splenic hemangiosarcoma,
hematoma, and nodular hyperplasia showed variable features.6
In a recent study, the triple-phase helical CT features of dif-
ferent splenic lesions were described, and in particular, nodular
hyperplasia showed a homogeneous normal enhancement pattern,
while hematoma and hemangiosarcoma displayed a heterogeneous
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pattern.7 Extramedullary hematopoiesis is defined as the formation
and development of blood cells outside the bone marrow.8 In adult
humans, EMH is seen in case of insufficient bone marrow function
or can be incidentally discovered during evaluation for unrelated
reasons.9 The liver and spleen are the two most common abdom-
inal locations of EMH in people, most commonly manifesting as
organomegaly and less commonly with focal mass-like lesions.10,11
The spleen is a common site of EHM in dogs. Studies indicate that,
in this species, EMH can occur in association with degenerative and
inflammatory conditions, including hemolytic anemia, myeloprolifer-
ative and lymphoproliferative disorders, and thrombosis; although in
most cases can occur independently or without an obvious underlying
cause.3,8,12-14 Despite the frequency with which EMH is found in the
spleen of canine patient, studies regarding its CT characteristics are
lacking. The aim of the current studywas to describemultidetector CT
(MDCT) features of splenic EMH in dogs.
2 MATERIALS AND METHODS
2.1 Study design, sample, and setting
This was a single-center descriptive retrospective study. The sample
population included client-owned dogs that underwent CT examina-
tions for varying purposes. All collection procedures were performed
at the Diagnostic and Interventional Radiology Division of the San
Marco Veterinary Clinic solely for dog’s benefit and for standard diag-
nostic and monitoring purposes. Previous informed written consent
was obtained from all dog owners. All the procedures performed com-
plied with the European legislation “on the protection of animals used
for scientific purposes” (Directive 2010/63/EU) and with the ethical
requirement of the Italian law (Decreto Legislativo 04/03/2014, n. 26).
All dogs that had undergone CT examination of the abdomen
between January 2014 and March 2019 were considered for inclu-
sion in the study. Eligibility criteria and information required were:
(a) cytological diagnosis of splenic EMH, (b) multiphase abdominal
CT, (c) complete anamnestic, clinical, and clinic-pathological evalua-
tion available (for further study; results will not be reported here).
Results of histopathology of the spleen, when available, were also
recorded. Patientswith concomitant cytological or histological diagno-
sis of splenic neoplasia were excluded from this study, as well as those
having a single phaseMDCT examination.
All decisions for dog inclusion or exclusion were made by a consen-
sus of two authors, a veterinary clinical pathologist and a veterinarian
with expertise in CT imaging (M.C. and G.B., respectively).
2.2 Image analyses, interpretation, and CT data
registration
The CT examinations were retrieved from the PACS (Picture Archiv-
ing Communication System - syngo.plaza, Siemens Healthineers,
Milano IT) and analyzed using a dedicated freestanding workstation
and vendor-specific postprocessing software (Syngo.Via, Siemens,
Germany) by two authors with 2 and 18 years of experience in MDCT
imaging (A.C. and G.B.). The reviewers were aware of the diagnosis of
splenic EMH (major inclusion criterium) at the time of interpretation of
the images, but were unaware of the previous clinical report. Volume
CT datasets obtained from the mixed (100-150 kVp) portal venous
phase were used for the study. Images were interpreted by both
authors together to reach a consensus, using a combination of 2D
multiplanar reformations, and 3D volume rendered postprocessing
techniques. For image analyses, window settings in different vascular
phases were dynamically adjusted to obtain a comprehensive visual
estimation of the spleen characteristics (from 190 to 480 window
width and from 16 to 90window level).
The following CT qualitative characteristics were recorded for
each dog finally recruited for the study: (a) dimension of the
spleen, evaluated subjectively (normal/enlarged); (b) appearance
of the parenchyma: normal, diffusely heterogeneous, presence of
focal/multifocal nodules (<1 cm) or presence of one (or more) mass
(>1 cm). The appearance of the parenchyma was defined “normal,”
when the spleen showed completely homogeneous enhancement or
when it had heterogeneous enhancement in early phases, reflecting
variable blooddistributionbetween the red andwhite pulps andhomo-
geneous enhancement in late phases.
The parenchyma was defined “heterogeneous” when it was hetero-
geneous in all phases and with focal/multifocal nodular aspect when
one or multiple nodules were present within the parenchyma. When
lesions were bigger than 1 cm, they were considered as masses, as in
previous study.6 The quantitative assessment of the spleen included:
(a) the attenuation value (expressed in HU) of the spleen parenchyma
and of the focal areas in all three vascular phases.Measurements were
made drawing a round region of interest (ROI) for the focal area and
another one, of the same size, for the surrounding splenic parenchyma
having normal appearance. The mean, minimum, and maximum atten-
uation value was each time recorded.
2.3 Statistical method
Data analyses were selected and performed by one board certified
clinical pathologist (M.C., PhD in Clinical Epidemiology and Biostatis-
tics Diplomate) using dedicated analysis software (Microsoft Excel,
1997–2018; Analyse-IT Software LTD). For the statistical analysis, a
Shapiro-Wilk test was performed to test the distribution of data. Dif-
ferent factors (age,weight, sex, sexual condition)were testedbothwith
univariable and multivariable analyses (ANOVA-MANOVA) to assess
any influence of these factor on the mean attenuation values. Dif-
ferences between the mean of the means/medians HU of the spleen
and mean of the means/medians of the lesions were tested with a
Wilcoxon-Mann-Whitney test. Significance level was set at 𝛼 = .05.
3 RESULTS
Eighty-nine dogs met the inclusion criteria; 43 were females and 46
were males. The median age was 10.7 years and median weight 21.7
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kg. Twenty-eight of 89 dogs were crossbreed dogs, while nine were
Labrador Retrievers, five Golden Retrievers, five Beagles, four Cocker
Spaniels, three Boxers, three Yorkshire Terriers, two German Shep-
herds, two Rottweilers, two Bichon Frises, two Maltese dogs, and two
Poodles, and one each of the following breeds: Alaskan Malamute,
Boston Terrier, Flat Coated Retriever, Greyhound, Medium Schnauzer,
Giant Schnauzer, Scottish Terrier, Siberian Husky, Italian Spinone,
Tibetan Terrier, Airedale Terrier, American Staffordshire Terrier, Bob-
tail, Bernese Mountain dog, English Bulldog, Pug, Chihuahua, Jack
Russell Terrier, Pastore Bergamasco, Weimaraner, Whippet, andWest
HighlandWhite Terrier.
3.1 CT scanning techniques
Multiphase CT data were obtained with a second or third generation
dual-source CT (128 × 2 or 192 × 2 dual-source CT; Somatom Defini-
tion Flash or Force; Siemens, Erlangen, Germany). Three-phases tomo-
graphic studies of the abdomen were consistently obtained with the
patient in the sternal recumbency on the CT table, head first and scan-
ning in cranio-caudal direction. An iodinated contrast agent (iohexol
370 mgI/mL, 2 mL/kg dosage followed by a saline flush) was each
time injected in a cephalic vein at an injection rate varying between
1.5 and 5 mL/s depending on the dog size (from 1.5 to 2 mL/s for
dogs <15 kg and from 2 to 5 mL/s for larger dogs) using a dual barrel
injector system.15 A bolus tracking techniquewas always used to tailor
the arterial phase on the patient. With the bolus-triggering technique
used, an ROI was placed in the descending aorta, at diaphragmatic
level; a series of low-dose, nonincremental scans were obtained and
the attenuation within the ROI constantly automatically monitored.15
The acquisition of the arterial phase started automatically when a pre-
set enhancement of 100 HU was reached within the aorta.15 A stan-
darddelayof20 swaspreset between thearterial and theportal phase;
interstitial phase was acquired between 3 and 5 min after the end of
the contrast agent injection.15 Computed tomography settings were
as follows: one tube for arterial and interstitial phase (120 kVp) and
two tubes for portal venous phase at 100/140 kVp. For all phases,
400mAs/rotation (0.28 s), collimation 128/192×0.6mm; imageswere
reconstructed at 0.3mmusing a soft-tissue reconstruction algorithm.
3.2 CT findings
The first qualitative feature considered was the dimension of the
spleen, evaluated subjectively with the use of both 2D-multiplanar
reformation (Figure 1A-C) and 3D-volume rendering (Figure 1D) tech-
niques: 26 of 89 dogs (29%) showed subjective splenomegaly, while in
the remaining 63 of 89 (71%) dogs, the size of the spleen was consid-
ered normal. The focal/multifocal nodular aspect (Figure 2D) was the
most frequent one, present in 55 of 89 dogs (62%). In the remaining
cases, the appearance of the parenchyma was considered normal in
eight of 89dogs (9%) (Figure2A), heterogeneous in12of89dogs (13%)
(Figure 2B), and in 14 of 89 dogs (16%), a splenic mass was present
(Figure 2C). No dogs with more than one mass were included.
Most of the lesions appeared hyperattenuating to the surrounding
parenchyma, especially in arterial (57/89, 64%; Figure 3A) and portal
phases (59/89, 66%; Figure 3B), while in interstitial phase, 40 of 89
(45%) dogswere hyperattenuating and39of 89 (44%) dogswere isoat-
tenuating (Figure3C). In 10of89 (11%) cases, the lesionswerehypoat-
tenuating with respect to the splenic parenchyma in the three phases.
The medians/means of the mean attenuations of the lesions and
the spleen in all phases are reported in Table 1. The difference of
the mean attenuation between the lesions and the parenchyma was
significantly higher in arterial and portal phases than in interstitial
phase (P < .0001; Figure 4). Attenuation was not influenced by age,
weight, sex, and sexual condition neither in univariable nor in multi-
variable analyses. When considering the masses alone, the majority
of them were hyper or hypoattenuating to the surrounding splenic
parenchyma in all phases; three of 14 were heterogeneously hypoat-
tenuating, but showed a hyperattenuating peripheral rim of enhance-
ment (Figure 5). The results regarding the appearance of the splenic
masses are reported in detail in the Tables 2 and 3. Four out of the 14
dogs with splenic masses were subjected to splenectomy, and the fol-
lowing histological examination confirmed the diagnosis of EMH,with-
out underlying neoplastic causes.
4 DISCUSSION
The multiphase-MDCT features of EMH in the spleen of dogs were
for the first time described in this study. According our results, splenic
EMH in dogs can show different presentations. The presence of mul-
tiple hyperattenuating nodules, especially visible in arterial and portal
phases, was the most frequent finding. Other features, less frequent,
were the presence of diffusely heterogeneous parenchyma, splenic
mass, and splenomegaly, although also cases with normal appearance
of the spleen were recorded.
The most frequent MDCT aspect of EMH was a multifocal nodular
aspect, hyperattenuating to the normal spleen: due to the hematopoi-
etic activity, the nodules appeared markedly hypervascular with
respect to the surrounding parenchyma. This result is in agreement
with previous studies, in which benign lesions were described to be
hyperattenuating to the remaining splenic parenchyma after contrast
administration, although EMH nodules were not described in these
studies.5,7
Nodules of EMH in the spleen were more hyperattenuating com-
pared to the rest of the parenchyma in the arterial and portal phases,
as the difference of the mean attenuation between the hyperattenu-
ating lesions and the parenchyma was significantly higher in arterial
and portal phases than in interstitial phase (P < .0001). This result
supports the theory of active nodules, in which the blood supply is
higher in early phases due to the hematopoietic activity; in the equi-
librium phase, these nodules tend to become isoattenuating to the rest
of the parenchyma, and are subsequently less visible. A normal post-
contrast splenic enhancementwas found in9%of thedogsof this study,
and 13% showed a diffusely heterogeneous pattern of enhancement.
These two conditions could reflect the fact that EMH in the spleen of
dogs can be diffuse, and not only nodular.8
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F IGURE 1 Example of splenomegaly. Two different 3D image volume techniques were used: multiplanar reformation (MPR), in which the
three orthogonal imaging planes are seen (A, transverse plane; B, dorsal plane; C, sagittal plane) and permit to identify the enlargement of the
spleen in all three planes (width, height, length), and volume rendering (VR) technique (ventral view) (D), helpful to display anatomical structures in
an interactive and 3Dway. In this case, the spleen was subjectively considered enlarged because was bigger than expected for a patient under
general anesthesia, and tend to displace the intestinal loops, as seen in the VR image. Abbreviations: S, spleen; LK, left kidney; L, liver [Color figure
can be viewed at wileyonlinelibrary.com]
F IGURE 2 Different appearances of splenic parenchyma (transverse sections). A, Normal enhancement of splenic parenchyma, homogeneous.
B, Diffusely heterogeneous enhancement of the spleen, no focal lesion detected. C, Splenic mass: a rounded, well-defined, heterogeneously
enhancingmass is deforming the splenic profile at the level of the head (arrow). D,Multifocal nodular aspect: multiple, rounded, well-defined,
hyperattenuating nodules are visible throughout the whole splenic parenchyma (arrowheads). Abbreviations: S, spleen; LK, left kidney; RK, right
kidney
In 16% of the cases, a splenic mass was present. In humans, the
EMH in the spleen can present as a focal mass, but is much less
common than the diffuse presentation10,11 and CT appearance of
EMH can consist of heterogeneous, hypovascular soft-tissuemasses11
or of well-defined, highly and heterogeneously enhanced lesion.16,17
Also, in this study, both hypervascular and hypovascular masses were
seen, and this result is in agreement with previous study in dogs
in which malignant and non-malignant splenic masses showed vari-
able CT features.6 In another study, benign splenic masses showed
homogeneous normal enhancementwhilemalignantmasses were het-
erogeneously poorly to remarkably enhancing,7 although in these
studies only nodular hyperplasia was described and no patients with
extramedullary hematopoiesis were included.6,7
In some cases, EMH appeared as a mass hypoattenuating to the
adjacent splenic parenchyma in all three phases, with a peripheral
rim of enhancement. The presence of hypoattenuating areas could
be explained with the presence of inactive EMH lesions, in which
iron deposition and fatty infiltration are the predominant features,
as described in human medicine.16,18 The hypervascular masses, as
well as the hypervascular rim, are most likely consistent with active
hematopoietic areas in the spleen.16,18
Splenic enlargement is the most frequent imaging appearance
of intra-abdominal EMH reported in in people.10,11 The spleen
was subjectively evaluated “larger than expected” only in 29% of
the dogs included here. This difference could reflect biological dif-
ferences in EHM between the two species as well as technical
issues. Indeed, the presence of splenomegaly in dogs is normally
subjectively evaluated, because standardized ranges for different
breed and sizes are lacking. Again, all dogs included in this study
underwent MDCT examination under general anesthesia, condition
that can affect the size of the spleen, depending on the protocol
used.19,20
This study has some limitations. First of all, the cytological diagnosis
of EMH and the histological confirmation in a limited number of cases.
Cytology can be considered as the gold standard for the diagnosis
of EMH in dogs8,12 but with histology it is also possible to exclude
other conditions (as neoplasia) involving the spleen at the same time.
Another limitation is the ultrasound guided samples of the lesions
we found in CT; sometimes, due to the vascular origin of the nodules,
they are not visible on ultrasound. We tried to minimize this limitation
performing the samples directly on CT table, immediately after the
MDCT exam.
In conclusion, based on our review of the literature, this is the first
published study describing theMDCT features of splenic EMH in dogs
and the use of a three-phase, bolus-triggered MDCT technique for
the evaluation of the spleen. The most frequent appearance consisted
CORDELLA ET AL. 5
F IGURE 3 Different aspects of the same spleen in three vascular phases. On top, different enhancement of the liver and great vessels in the
three phases (transverse sections): A1, arterial phase; B1, portal phase; C1, interstitial phase. Abbreviations: Ao, aorta; PV, portal vein; CVC, caudal
vena cava. Below, the appearance of the same spleen in the three phases (dorsal sections): A, arterial phase;B, portal phase; C, interstitial phase.
Note that themultiple hyperattenuating nodules, well seen in late arterial and portal phases, are not visible in interstitial phase
TABLE 1 Means (or median) of themean attenuations of the lesions and the respective splenic parenchyma in all phases
Mean (SD) (HU) Min (HU) Max (HU)
Phase Spleen Lesions Spleen Lesions Spleen Lesions
Arterial 74 (12.7) 109 (52.3)* 56 45 124 223
Portal 92.8 (13.4) 122.2 (29.5) 54 47 127 206
Interstitial 93 (11.2) 106.7 (22.9) 65 51 124 180
∗Data not normally distributed, presented asMedian (IQR) instead ofMean (SD).
Abbreviations: SD, standard deviation; IQR, interquartile range;Min, minimum;Max, maximum; HU, Hounsfield Units.
of multiple nodules, hypervascular to the rest of the parenchyma,
reflecting an active hematopoietic activity. These nodules were best
visualized in the arterial and portal phases, underlying the importance
to evaluate the spleen, as well as other abdominal organs, in different
vascular phases. Other aspects of splenic EMH included normal and
diffusely heterogeneous enhancement, reflecting the possibility of
a diffuse EMH in dogs, as well as presence of splenic masses. For
this reason, authors believe it is important to also include EMH as
differential diagnosis for splenicmasses in dogs. Further investigations
are needed to compare the findings described in this study andMDCT
features of other splenic diseases (neoplastic, inflammatory, vascular),
in order to assess the differences between EMH and other conditions,
and to establish key features that could permit the differentiation of
benign andmalignant processes in the spleen.
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F IGURE 4 Boxplot with whiskers fromminimum tomaximum graphic showing the degree of dispersion of the data inside each group. In
ordinate are reported the differences between themean values of mean attenuation (HU) between the lesions and the corresponding splenic
parenchyma, and in abscissa the three different vascular phases (groups): 0, arterial phase; 1, portal phase; 2, interstitial phase. The difference
between the differences of themean attenuation between lesions and parenchyma is statistically significant when comparing groups 0 and 2
(arterial-interstitial) (P< .0001) and groups 1 and 2 (portal-interstitial; P< .0001)
F IGURE 5 Three examples of splenic masses with hypervascular rim (dorsal views). Rounded, well-defined, heterogeneously hypoattenuating
masses are seen in the spleen (arrow), in two cases deforming the splenic profile (A, B) and in the other case within the parenchyma (C), in all three
cases, surrounded by amarkedly hyperattenuating rim (arrowheads). Abbreviations: S, spleen; L, liver; RK, right kidney
TABLE 2 Appearance of splenic masses (total: 14) compared to the splenic parenchyma in the three phases
Hyperattenuating Isoattenuating Hypoattenuating Hypoattenuating+ rim
Arterial 6 1 4 3
Portal 6 0 5 3
Interstitial 5 3 4 2
TABLE 3 Medians/means of themean attenuations of the 14masses and the respective splenic parenchyma in all phases
Mean (SD) (HU) Min (HU) Max (HU)
Phase Spleen Masses Spleen Masses Spleen Masses
Arterial 70.7 (11.8) 78.1 (46.3)* 61 45 83 140
Portal 98.8 (12.5) 93.3 (34.7)* 80 47 127 135
Interstitial 96.7 (11.3) 97.5 (24.5) 86 54 116 138
∗Data not normally distributed, presented asMedian (IQR) instead ofMean (SD).
Abbreviations: SD, standard deviation; IQR, interquartile range;Min, minimum;Max, maximum; HU, Hounsfield Units.
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